bioRxiv Science⌕ Search

Biology subjects

Sheth, P. M.

Publications and source records attributed to Sheth, P. M..

6 recordsLinked to original sources

Blocking primer improves detection of tick-borne pathogens in Ixodes scapularis (black-legged ticks) from a Lyme disease hotspot region in eastern Ontario, Canada.

Tick-borne pathogen (TBP) surveillance strategies that rely exclusively on targeted methods like PCR (PCR) or immunoblots do not benefit from strain-level sequence variation. Bacterial 16S rRNA metabarcoding offers more agnostic detection but is constrained in I. scapularis by the dominance of a maternally inherited endosymbiont, Rickettsia buchneri. Here we report the design and evaluation of three R. buchneri-specific blocking primers to suppress endosymbiont amplification during full-length 16S rRNA library preparation. Of these, primer 18F-Rb-C3 reduced R. buchneri relative abundance approximately 32-fold. We applied 18F-Rb-C3 with V4-16S metabarcode sequencing on 67 ticks collected from farm animals in Eastern Ontario and compared Borrelia species detection against qPCR. The V4-16S rRNA metabarcoding identified Borrelia species in 21 samples, whereas qPCR detected Borrelia in 24 samples and 11 samples were detected by both methods. Additionally, metabarcoding detected Anaplasma phagocytophilum in 12 samples, including seven samples coinfected with Borrelia, in the same assay. Variation relevant to strain surveillance was also detected by sequencing, though V4-16S was not sufficient to resolve closely related Borrelia genospecies or A. phagocytophilum variants. These findings demonstrate that blocking primer 18F-Rb-C3 enhances sensitivity of amplicon sequencing to the level of qPCR while also detecting other pathogens and sequence variants in a single assay.

genomics↗

Variations in carbapenem resistance associated with the VIM-1 metallo-β-lactamase across the Enterobacterales

The VIM-1 metallo-{beta}-lactamase enzyme, encoded as a cassette within class 1 integrons, is found in Gram-negative clinical isolates worldwide and has been linked to outbreaks of bacterial pathogens in nosocomial settings. Six vim-1+ clinical isolates, from the genera Escherichia, Klebsiella, and Enterobacter, were obtained from Kingston, Ontario, Canada. Whole genome sequencing revealed that vim-1 was plasmid-borne in all strains and situated as the first gene in In916 or In110 integrons. Analysis of related plasmids suggested that these vim-1-containing plasmids are globally disseminated and have spread via horizontal gene transfer and autochthonous vertical spread within Ontario. Interestingly, the minimum inhibitory concentrations of ertapenem and meropenem, two clinically relevant carbapenem antibiotics, against these six isolates varied more than tenfold, suggesting the effects of VIM-1 are dependent on the genomic content of the host microbe. To further study the genomic content dependency of VIM-1, we introduced vim-1 into three common Enterobacterales laboratory strains. Although introduction of vim-1 into Escherichia coli DH5 resulted in little resistance to ertapenem or meropenem, multiple rounds of adaptive laboratory evolution allowed us to identify variants with extremely high levels of resistance to both carbapenems. DNA sequencing revealed that the increase in carbapenem resistance was due to a combination of increased vim-1 gene dosage and epistatic interactions with mutations of ompC that likely would have decreased outer membrane permeability to these antibiotics. Together, these results provide additional support for the role of gene epistasis is modulating the antimicrobial resistance phenotypes of acquired resistance genes, as well as previous results suggesting that the presence of a {beta}-lactamase gene is insufficient to confer strong resistance to carbapenems without being paired with reduced outer membrane permeability.

microbiology↗

Rapid Detection of Carbapenemase-Producing Organisms Using a Luminescent Biosensor

Carbapenemase-producing organisms (CPOs) pose an urgent global health threat due to their ability to inactivate carbapenems, a group of last resort antibiotics. Infections caused by these pathogens are associated with poor patient outcomes, high mortality rates, and added burden to infection prevention and control programs, making early detection vital to ensure optimal antimicrobial therapy and appropriate implementation of infection control practices. In this study, we report the application of a luminescent whole-cell biosensor for the rapid detection of CPOs. This biosensor provides positive test results within 2.5 hours, inclusive of setup time, and has been validated with a panel of laboratory and clinical isolates producing a diverse range of carbapenemases (KPC, NDM, IMP, VIM and OXA-48-like). The assay successfully identified all CPO isolates tested with a sensitivity of 100%, including strains producing weak OXA-48-like carbapenemases which are sometimes missed by currently used detection methods. The assay also demonstrated a specificity of 100 %, with all non-CPO clinical isolates testing negative under the optimized assay conditions. Due to the rapid time-to-positivity, minimal setup requirements, and high sensitivity, this test could serve as an attractive alternative to CPO detection methods currently employed by clinical microbiology labs, and could also facilitate CPO screening in other settings (e.g., environmental, agricultural).

microbiology↗

Tiled PCR amplification-based Whole Genome Sequencing and Phylogenetic Classification Accelerate the Implementation of Respiratory Syncytial Virus Genomic surveillance in Canada as a Pilot Study

Whole genome sequencing (WGS) has emerged as a powerful tool to facilitate the study of existing and emerging infectious diseases. WGS-based genomic surveillance provides information on the genetic diversity and tracks the evolution of important viral pathogens including Respiratory Syncytial Virus (RSV). Development and implementation of robust tiled multiplex PCR amplification-based WGS assays will facilitate high-throughput RSV surveillance initiatives. In this study, we developed multiplex PCR assays for targeted enrichment of viral genomes using PrimalScheme (http://primal.zibraproject.org) to amplify over 97% of the genome in the majority of contemporaneous specimens tested. A pilot dataset comprising 52 RSVA and 37 RSVB genomes derived from Canadian clinical specimens during the 2022-2023 respiratory virus season were used to perform phylogenetic analyses using both near complete genome and Glycoprotein (G) sequences. Overall, the RSV phylogenetic tree built with whole genomes showed identical lineage clusters as that compared to the G gene, but showed more confidence and discriminatory features within individual lineage. Moreover, availability of whole genomes enabled the identification of a broader range of mutations, for instance the identified S377N, K272M, S276N, S211N, S206I and S209Q in Canadian fusion proteins that could be potentially associated with effectiveness of vaccines or antiviral-based therapeutics. In conclusion, the tiled-PCR amplification assays described offer a more streamlined approach to facilitate high-throughput, high sensitivity of RSV WGS, which is capable of supporting enhanced genomic surveillance initiatives, as well as the more comprehensive genomic analyses required to inform public health strategies for the development and usage of vaccines and antiviral drugs. IMPORTANCEWe present assays to efficiently sequence genomes of the RSVA and RSVB. This enables researchers and public health agencies to acquire high-quality genomic data using rapid and cost-effective approaches. Genomic data based comparative analysis can be used to conduct surveillance and monitor circulating isolates for efficacy of vaccines and antiviral therapeutics.

genomics↗

Development of a Whole-Cell Biosensor for β-Lactamase Inhibitor Discovery

The clinical utility of the {beta}-lactam antibiotics has been endangered by the production of {beta}-lactamases by {beta}-lactam-resistant pathogenic bacteria such as Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii. Collectively, these enzymes can degrade every clinically available {beta}-lactam, jeopardizing antimicrobial therapy. Although extensive efforts have been made to develop {beta}-lactamase inhibitors, inhibitor-resistant {beta}-lactamases emerge rapidly. In addition, there are currently no clinically available inhibitors against the metallo-{beta}-lactamases, a group of {beta}-lactamases of great global concern. To further inhibitor discovery efforts, new assays are required to assess inhibitor efficacy, particularly in a cellular context. We report the development of a whole-cell E. coli biosensor which can quantify {beta}-lactamase inhibition in a cellular context. Upon administration of an effective inhibitor, a {beta}-lactam is rescued from {beta}- lactamase-catalyzed degradation, resulting in the emission of a luminescent signal by the biosensor. This platform was validated using a panel of clinically relevant {beta}-lactamases and was applied to quantitatively study the potency of a selection of currently used and reported {beta}-lactamase inhibitors. This rapid method can account for factors like membrane permeability and can be employed to identify new {beta}-lactamase inhibitors.

microbiology↗

Chasing the origin of SARS-CoV-2 in Canada's COVID-19 cases: A genomics study

The emergence and global spread of SARS-CoV-2 has had profound social and economic consequences and has shed light on the importance of continued and additional investment in global health and infectious disease surveillance. Identifying changes in viral genomes provides key insights into viral diversity, how viruses spread within populations, and viral strategies for evasion of host immune systems. Here we report twenty-five SARS-CoV-2 genome sequences collected from some of the first COVID-19 cases in eastern Ontario, Canada (March 18-30, 2020). The reported genomes belong to the S-clade (n=2) and G-clade (n=23) of SARS-CoV-2 and contain 45 polymorphic sites including one shared missense and three unique synonymous variants in the gene encoding the spike protein. A phylogenetic analysis enabled the tracing of viral origin and potential transmission into and within Canada. There may be as many as sixteen unique infection events represented in these samples, including at least three that were likely introduced from Europe and seven from the USA. In addition, four separate genomes are each shared by multiple patients, suggesting a common origin or community spread even during this early stage of infection. These results demonstrate how molecular epidemiology and evolutionary phylogenetics can help local health units track origins and vectors of spread for emerging diseases like SARS-CoV-2. Earlier detection and screening in this way could improve the effectiveness of regional public health interventions to prevent future pandemics.

microbiology↗